Natdecita Injection 1's

Natdecita Injection belongs to the group of medicines called hypomethylation agents used to treat myelodysplastic syndrome. A myelodysplastic syndrome is a group of malignancies known as myelodysplastic syndromes that occur when immature blood cells in the bone marrow do not mature or turn into healthy blood cells.

Natdecita Injection contains ‘Decitabine’, which works by helping the bone marrow produce normal blood cells and kills abnormal cells in the bone marrow.

Decitabine should be administered to patients only in a hospital setting under the supervision of a physician qualified by training and experience to administer chemotherapeutic agents. Decitabine should usually be given for at least four cycles but may be continued if your doctor decides you will benefit from additional treatment. The most common adverse reactions of Natdecita Injection are injection site reactions, excessive tiredness, headache, dizziness, confusion, fast heartbeat, difficulty falling asleep or staying asleep, weakness, shortness of breath, nausea, constipation, diarrhoea, vomiting, heartburn, chest discomfort and swelling of the hands, feet, ankles, lower legs, or stomach. Talk with your doctor if you experience any of these side effects persistently.

Decitabine may harm your fetus. Avoid taking Natdecita Injection if you are pregnant or breastfeeding. You or your partner should not become pregnant while you are using decitabine. It would be best if you used birth control to prevent pregnancy in yourself or your partner during your treatment with decitabine and for two months afterwards. Call your doctor if you or your partner becomes pregnant while using decitabine. If you are breastfeeding. Do not breastfeed while you take this drug and for two weeks after your last dose. Natdecita Injection may cause dizziness, sleepiness, tiredness, and blurred vision, so drive only if alert. Natdecita Injection is not recommended for children below 18 years as safety and effectiveness have not been established. Inform your doctor about your health condition and medications before taking Natdecita Injection to rule out interactions.

Natdecita Injection is used to treat blood and bone marrow disorders. The detailed uses of Natdecita Injection are as follows:

• Treats myelodysplastic syndrome (MDS): Natdecita Injection helps manage a group of conditions where the bone marrow makes misshapen or insufficient healthy blood cells.
• Promotes healthy blood cell production: Natdecita Injection aids the bone marrow in producing normal blood cells.
• Targets abnormal bone marrow cells: Natdecita Injection works by destroying abnormal cells in the bone marrow to improve overall blood health.

• Typically, Natdecita Injection is given every 8 hours for 3 days, with cycles repeated every 6 weeks, or as recommended by your doctor.
• Natdecita Injection will be administered by a doctor or nurse in a healthcare facility.
• Do not self-administer.

Natdecita Injection belongs to the group of medicines called hypomethylation agents used to treat myelodysplastic syndrome. Natdecita Injection contains ‘Decitabine’, which works by helping the bone marrow produce normal blood cells and kills abnormal cells in the bone marrow. On the other hand, it can treat blood cancer, known as acute myeloid leukemia (AML).

Before taking the Natdecita Injection, let your doctor know about all your medical conditions, sensitivities, and medications you are using. Before and during your therapy, your doctor will prescribe laboratory testing on a regular basis. You may have a higher risk of infection. Hands must be washed frequently. Avoid contact with those who have illnesses, colds, or the flu. You may bleed more easily. Take precautions to avoid injury. Do not skip any scheduled dose or take other medications unless prescribed by the doctor.